University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
30 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Illinois (UOL) is a public research university that offers undergraduate, graduate, and professional programs. The university offers online and continuing education programs such as undergraduate and graduate online degrees. It provides research activities in the areas of alternative, complementary and traditional medicine; biotechnology and biodefense; cancer biology and therapeutics; drug discovery, development and delivery; infectious diseases; natural products; neuroscience; patient safety; and pharmacoeconomics.

University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target

  
Source:
Document ID
GDPH43936D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Illinois, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Illinois, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Illinois, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Illinois, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Illinois, Medical Devices Deals, 2010 to YTD 201691
University of Illinois, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
University of Illinois, Pharmaceuticals &Healthcare, Deal Details1214
  Partnerships121
    Mayo Clinic Enters Into Agreement With University of Illinois121
  Licensing Agreements131
    Ocugen Enters into Licensing Agreement with University of Illinois at Chicago131
    Revolution Medicines Enters into Licensing Agreement with University of Illinois141
    Cortex Pharma Enters into Licensing Agreement with University of Illinois151
    zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign161
    University of Illinois Terminates Licensing Agreement With Pier Pharma For Dronabinol171
    University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds182
    Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois201
    AllyChem Enters Into Licensing Agreement With University of Illinois211
    Catylix Enters Into Licensing Agreement With The University Of Illinois At Urbana-Champaign221
    ImmuVen Enters Into Licensing Agreement With University Of Illinois231
    University of Illinois At Urbana-Champaign Enters Into Licensing Agreement With Gelest241
    University Of Illinois At Urbana-Champaign Enters Into Licensing Agreement With Sigma-Aldrich251
University of Illinois - Key Competitors261
Key Employees271
Locations And Subsidiaries282
  Head Office281
  Other Locations &Subsidiaries282
Appendix301
  Methodology301
  About GlobalData301
  Contact Us301
  Disclaimer301

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Illinois-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7803>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Illinois-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7803>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research